Ovarian cancer stem cells: Are they real and why are they important?

Gynecologic Oncology

Volumn 132, Issue 2, 2014, Pages 483-489

  Shah, Monjri M ^a   Landen, Charles N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

ALDH1; Cancer stem cells; CD133; CD44; Ovarian cancer; Side population

Indexed keywords

ALDH1; CANCER STEM CELLS; CD133; CD44; OVARIAN CANCER; SIDE POPULATION;

ANIMALS; FEMALE; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84894083580     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.12.001     Document Type: Review

References (74)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 1 Jan 2013 11 30 (PubMed PMID: 23335087)
2. A.C. Society Colorectal cancer statistics: American Cancer Society; 2011 [cited] 2011 November 1
3. A.C. Society Pancreatic cancer statistics: American Cancer Society; 2011 [cited] November 1, 2011
4. T.A. Yap, M. Gerlinger, P.A. Futreal, L. Pusztai, and C. Swanton Intratumor heterogeneity: seeing the wood for the trees Sci Transl Med 4 127 Mar 28, 2012 (127ps10. PubMed PMID: 22461637)
5. T. Lapidot, C. Sirard, J. Vormoor, B. Murdoch, T. Hoang, and J. Caceres-Cortes et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Nature 367 6464 Feb 17, 1994 645 648 (PubMed PMID: 7509044. Epub 1994/02/17. eng.)
6. R. Foster, R.J. Buckanovich, and B.R. Rueda Ovarian cancer stem cells: working towards the root of stemness Cancer Lett 338 1 Sep 10, 2013 147 157 (PubMed PMID: 23138176)
7. J.A. Magee, E. Piskounova, and S.J. Morrison Cancer stem cells: impact, heterogeneity, and uncertainty Cancer Cell 21 3 Mar 20, 2012 283 296 (PubMed PMID: 22439924)
8. K. Sundfeldt, Y. Piontkewitz, K. Ivarsson, O. Nilsson, P. Hellberg, and M. Brannstrom et al. E-cadherin expression in human epithelial ovarian cancer and normal ovary Int J Cancer 74 3 Jun 20, 1997 275 280 (PubMed PMID: 9221804)
9. N. Auersperg, J. Pan, B.D. Grove, T. Peterson, J. Fisher, and S. Maines-Bandiera et al. E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium Proc Natl Acad Sci U S A 96 11 May 25, 1999 6249 6254 (PubMed PMID: 10339573. Pubmed Central PMCID: 26867. Epub 1999/05/26. eng)
10. N.J. Bowen, L.D. Walker, L.V. Matyunina, S. Logani, K.A. Totten, and B.B. Benigno et al. Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells BMC Med Genet 2 71 2009 (PubMed PMID: 20040092. Pubmed Central PMCID: 2806370. Epub 2009/12/31. eng)
11. P.P. Szotek, H.L. Chang, K. Brennand, A. Fujino, R. Pieretti-Vanmarcke, and C. Lo Celso et al. Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics Proc Natl Acad Sci U S A 105 34 Aug 26, 2008 12469 12473 (PubMed PMID: 18711140. Pubmed Central PMCID: 2527935)
12. N. Auersperg The stem-cell profile of ovarian surface epithelium is reproduced in the oviductal fimbriae, with increased stem-cell marker density in distal parts of the fimbriae Int J Gynecol Pathol 32 5 Jul 25, 2013 (PubMed PMID: 23896717)
13. A. Humphries, B. Cereser, L.J. Gay, D.S. Miller, B. Das, and A. Gutteridge et al. Lineage tracing reveals multipotent stem cells maintain human adenomas and the pattern of clonal expansion in tumor evolution Proc Natl Acad Sci U S A 110 27 Jul 2, 2013 E2490 E2499 (PubMed PMID: 23766371. Pubmed Central PMCID: 3704042)
14. C. Cobaleda, W. Jochum, and M. Busslinger Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors Nature 449 7161 Sep 27, 2007 473 477 (PubMed PMID: 17851532)
15. H. Xie, M. Ye, R. Feng, and T. Graf Stepwise reprogramming of B cells into macrophages Cell 117 5 May 28, 2004 663 676 (PubMed PMID: 15163413)
16. P.R. Tata, H. Mou, A. Pardo-Saganta, R. Zhao, M. Prabhu, and B.M. Law et al. Dedifferentiation of committed epithelial cells into stem cells in vivo Nature 503 7475 Nov 14, 2013 218 223 (PubMed PMID: 24196716)
17. S.K. Singh, C. Hawkins, I.D. Clarke, J.A. Squire, J. Bayani, and T. Hide et al. Identification of human brain tumour initiating cells Nature 432 7015 Nov 18, 2004 396 401 (PubMed PMID: 15549107. eng.)
18. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci U S A 100 7 Apr 1, 2003 3983 3988 (PubMed PMID: 12629218. Pubmed Central PMCID: 153034. Epub 2003/03/12. eng)
19. Z. Dobbin, and C. Landen Isolation and characterization of potential cancer stem cells from solid human tumors - potential applications Curr Protoc Pharmacol 63 14 2013 (in press)
20. S.A. Bapat, A.M. Mali, C.B. Koppikar, and N.K. Kurrey Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer Cancer Res 65 8 Apr 15, 2005 3025 3029 (PubMed PMID: 15833827)
21. T. Liu, W. Cheng, D. Lai, Y. Huang, and L. Guo Characterization of primary ovarian cancer cells in different culture systems Oncol Rep 23 5 May 2010 1277 1284 (PubMed PMID: 20372841)
22. T. Reya, S.J. Morrison, M.F. Clarke, and I.L. Weissman Stem cells, cancer, and cancer stem cells Nature 414 6859 Nov 1, 2001 105 111 (PubMed PMID: 11689955. Epub 2001/11/02. eng.)
23. M.A. Abitorabi, R.K. Pachynski, R.E. Ferrando, M. Tidswell, and D.J. Erle Presentation of integrins on leukocyte microvilli: a role for the extracellular domain in determining membrane localization J Cell Biol 139 2 Oct 20, 1997 563 571 (PubMed PMID: 9334357)
24. M. Zoller CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11 4 Apr 2011 254 267 (PubMed PMID: 21390059)
25. J. Lennartsson, and L. Ronnstrand The stem cell factor receptor/c-Kit as a drug target in cancer Curr Cancer Drug Targets 6 1 Feb 2006 65 75 (PubMed PMID: 16475976)
26. C.N. Landen Jr., B. Goodman, A.A. Katre, A.D. Steg, A.M. Nick, and R.L. Stone et al. Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer Mol Cancer Ther 9 12 Dec 2010 3186 3199 (PubMed PMID: 20889728. Pubmed Central PMCID: 3005138)
27. I.A. Silva, S. Bai, K. McLean, K. Yang, K. Griffith, and D. Thomas et al. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival Cancer Res 71 11 May 24, 2011 3991 4001 (PubMed PMID: 21498635. Epub 2011/04/19. Eng)
28. S. Deng, X. Yang, H. Lassus, S. Liang, S. Kaur, and Q. Ye et al. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers PLoS One 5 4 2010 e10277 (PubMed PMID: 20422001. Pubmed Central PMCID: 2858084. Epub 2010/04/28. eng)
29. J. Zhang, X. Guo, D.Y. Chang, D.G. Rosen, I. Mercado-Uribe, and J. Liu CD133 expression associated with poor prognosis in ovarian cancer Mod Pathol 25 3 Nov 11, 2011 456 464 (PubMed PMID: 22080056. Epub 2011/11/15. Eng)
30. K.D. Steffensen, A.B. Alvero, Y. Yang, M. Waldstrom, P. Hui, and J.C. Holmberg et al. Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer J Oncol 2011 2011 620523 (PubMed PMID: 21904548. Pubmed Central PMCID: 3166719. Epub 2011/09/10. eng)
31. S. Rizzo, J.M. Hersey, P. Mellor, W. Dai, A. Santos-Silva, and D. Liber et al. Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2 Mol Cancer Ther 10 2 Feb 2011 325 335 (PubMed PMID: 21216927. Pubmed Central PMCID: 3037846. Epub 2011/01/11. eng)
32. B. Aktas, M. Tewes, T. Fehm, S. Hauch, R. Kimmig, and S. Kasimir-Bauer Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients Breast Cancer Res 11 4 2009 R46 (PubMed PMID: 19589136. Pubmed Central PMCID: 2750105. Epub 2009/07/11. eng)
33. H. Iinuma, T. Watanabe, K. Mimori, M. Adachi, N. Hayashi, and J. Tamura et al. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer J Clin Oncol 29 12 Apr 20, 2011 1547 1555 (PubMed PMID: 21422427. Epub 2011/03/23. eng)
34. K. Kulkarni-Datar, S. Orsulic, R. Foster, and B.R. Rueda Ovarian tumor initiating cell populations persist following paclitaxel and carboplatin chemotherapy treatment in vivo Cancer Lett 339 2 Jun 18, 2013 237 246 (PubMed PMID: 23791886)
35. A.D. Steg, K.S. Bevis, A.A. Katre, A. Ziebarth, Z.C. Dobbin, and R.D. Alvarez et al. Stem cell pathways contribute to clinical chemoresistance in ovarian cancer Clin Cancer Res 18 3 Feb 1, 2012 869 881 (PubMed PMID: 22142828. Pubmed Central PMCID: 3271164)
36. P.P. Szotek, R. Pieretti-Vanmarcke, P.T. Masiakos, D.M. Dinulescu, D. Connolly, and R. Foster et al. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness Proc Natl Acad Sci U S A 103 30 Jul 25, 2006 11154 11159 (PubMed PMID: 16849428. eng)
37. X. Wei, D. Dombkowski, K. Meirelles, R. Pieretti-Vanmarcke, P.P. Szotek, and H.L. Chang et al. Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics Proc Natl Acad Sci U S A 107 44 Nov 2, 2010 18874 18879 (PubMed PMID: 20952655. Pubmed Central PMCID: 2973919. Epub 2010/10/19. eng)
38. L.Y. Bourguignon, K. Peyrollier, W. Xia, and Gilad E. Hyaluronan CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells J Biol Chem 283 25 Jun 20, 2008 17635 17651 (PubMed PMID: 18441325. Pubmed Central PMCID: 2427357. Epub 2008/04/29. eng)
39. M.G. Slomiany, L. Dai, L.B. Tolliver, G.D. Grass, Y. Zeng, and B.P. Toole Inhibition of functional hyaluronan-CD44 interactions in CD133-positive primary human ovarian carcinoma cells by small hyaluronan oligosaccharides Clin Cancer Res 15 24 Dec 15, 2009 7593 7601 (PubMed PMID: 19996211. Pubmed Central PMCID: 2794991. Epub 2009/12/10. Eng)
40. F. Casagrande, E. Cocco, S. Bellone, C.E. Richter, M. Bellone, and P. Todeschini et al. Eradication of chemotherapy-resistant CD44 + human ovarian cancer stem cells in mice by intraperitoneal administration of clostridium perfringens enterotoxin Cancer 117 24 Jun 20, 2011 5519 5528 (PubMed PMID: 21692061. Epub 2011/06/22. Eng)
41. V. Shah, O. Taratula, G.O. Garbuzenko, O.R. Taratula, L. Rodriguez-Rodriguez, and T. Minko Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug Clin Cancer Res 19 22 Sep 13, 2013 6193 6204 (PubMed PMID: 24036854)
42. J.T. Park, M. Li, K. Nakayama, T.L. Mao, B. Davidson, and Z. Zhang et al. Notch3 gene amplification in ovarian cancer Cancer Res 66 12 Jun 15, 2006 6312 6318 (PubMed PMID: 16778208. eng)
43. S.M. McAuliffe, S.L. Morgan, G.A. Wyant, L.T. Tran, K.W. Muto, and Y.S. Chen et al. Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy Proc Natl Acad Sci U S A 109 43 Oct 23, 2012 E2939 E2948 (PubMed PMID: 23019585. Pubmed Central PMCID: 3491453)
44. A.D. Steg, A.A. Katre, K.S. Bevis, A. Ziebarth, Z.C. Dobbin, and M.M. Shah et al. Smoothened antagonists reverse taxane resistance in ovarian cancer Mol Cancer Ther 11 7 Jul 2012 1587 1597 (PubMed PMID: 22553355. Pubmed Central PMCID: 3392529)
45. A. Ray, E. Meng, E. Reed, L.A. Shevde, and R.P. Rocconi Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells Int J Oncol 39 4 Oct 2011 797 804 (PubMed PMID: 21701772)
46. H. Wang, L. Fan, X. Xia, Y. Rao, Q. Ma, and J. Yang et al. Silencing Wnt2B by siRNA interference inhibits metastasis and enhances chemotherapy sensitivity in ovarian cancer Int J Gynecol Cancer 22 5 Jun 2012 755 761 (PubMed PMID: 22635028)
47. W.K. Chau, C.K. Ip, A.S. Mak, H.C. Lai, and A.S. Wong c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/beta-catenin-ATP-binding cassette G2 signaling Oncogene 32 22 May 30, 2013 2767 2781 (PubMed PMID: 22797058)
48. B.G. Bitler, J.P. Nicodemus, H. Li, Q. Cai, H. Wu, and X. Hua et al. Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence Cancer Res 71 19 Aug 4, 2011 6184 6194 (PubMed PMID: 21816908. Epub 2011/08/06. Eng)
49. A.B. Alvero, M.K. Montagna, J.C. Holmberg, V. Craveiro, D. Brown, and G. Mor Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells Mol Cancer Ther 10 8 Aug 2011 1385 1393 (PubMed PMID: 21677151. Epub 2011/06/17. eng)
50. A.B. Alvero, M.K. Montagna, R. Chen, K.H. Kim, K. Kyungjin, and I. Visintin et al. NV-128, a novel isoflavone derivative, induces caspase-independent cell death through the Akt/mammalian target of rapamycin pathway Cancer 115 14 Jul 15, 2009 3204 3216 (PubMed PMID: 19472400. Pubmed Central PMCID: 2757274. Epub 2009/05/28. eng)
51. H. Chen, T.M. Hardy, and Tollefsbol TO Epigenomics of ovarian cancer and its chemoprevention Front Genet 2 67 2011 (PubMed PMID: 22303362. Pubmed Central PMCID: 3268620)
52. C. Balch, F. Fang, D.E. Matei, T.H. Huang, and K.P. Nephew Minireview: epigenetic changes in ovarian cancer Endocrinology 150 9 Sep 2009 4003 4011 (PubMed PMID: 19574400. Pubmed Central PMCID: 2736079)
53. R.L. Huang, F. Gu, N.B. Kirma, J. Ruan, C.L. Chen, and H.C. Wang et al. Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers Epigenetics 8 6 May 10, 2013 (PubMed PMID: 23774800)
54. C. Ivan, W. Hu, J. Bottsford-Miller, B. Zand, H.J. Dalton, and T. Liu et al. Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer Gynecol Oncol 128 3 Mar 2013 506 511
55. D. Matei, F. Fang, C. Shen, J. Schilder, A. Arnold, and Y. Zeng et al. Epigenetic resensitization to platinum in ovarian cancer Cancer Res 72 9 May 1, 2012 2197 2205 (PubMed PMID: 22549947. Pubmed Central PMCID: 3700422)
56. S. Hu, L. Yu, Z. Li, Y. Shen, J. Wang, and J. Cai et al. Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo Cancer Biol Ther 10 8 Oct 15, 2010 788 795 (PubMed PMID: 20686362)
57. C. Yang, J. Cai, Q. Wang, H. Tang, J. Cao, and L. Wu et al. Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1 Gynecol Oncol 124 2 Feb 2012 325 334
58. D.S. Alberts, E.V. Hannigan, P.Y. Liu, C. Jiang, S. Wilczynski, and L. Copeland et al. Randomized trial of adjuvant intraperitoneal alpha-interferon in stage III ovarian cancer patients who have no evidence of disease after primary surgery and chemotherapy: an intergroup study Gynecol Oncol 100 1 Jan 2006 133 138
59. J.S. Berek, M. Markman, J.A. Blessing, P.R. Kucera, B.E. Nelson, and B. Anderson et al. Intraperitoneal alpha-interferon alternating with cisplatin in residual ovarian carcinoma: a phase II Gynecologic Oncology Group study Gynecol Oncol 74 1 Jul 1999 48 52
60. L. Moserle, S. Indraccolo, M. Ghisi, C. Frasson, E. Fortunato, and S. Canevari et al. The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects Cancer Res 68 14 Jul 15, 2008 5658 5668 (PubMed PMID: 18632618. Epub 2008/07/18. eng)
61. Y. Kobayashi, K. Seino, S. Hosonuma, T. Ohara, H. Itamochi, and S. Isonishi et al. Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin Gynecol Oncol 121 2 May 1, 2011 390 394
62. S. Pellegatta, P.L. Poliani, D. Corno, F. Menghi, F. Ghielmetti, and B. Suarez-Merino et al. Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas Cancer Res 66 21 Nov 1, 2006 10247 10252 (PubMed PMID: 17079441. Epub 2006/11/03. eng)
63. Q. Xu, G. Liu, X. Yuan, M. Xu, H. Wang, and J. Ji et al. Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens (Dayton, Ohio) Stem Cells 27 8 Aug 2009 1734 1740 (PubMed PMID: 19536809)
64. D. Weng, B. Song, J. Durfee, V. Sugiyama, Z. Wu, and S. Koido et al. Induction of cytotoxic T lymphocytes against ovarian cancer-initiating cells Int J Cancer 129 8 Oct 15, 2011 1990 2001 (PubMed PMID: 21154809. Epub 2010/12/15. Eng)
65. T. Baba, P.A. Convery, N. Matsumura, R.S. Whitaker, E. Kondoh, and T. Perry et al. Epigenetic regulation of CD133 and tumorigenicity of CD133 + ovarian cancer cells Oncogene 28 2 Jan 15, 2009 209 218 (PubMed PMID: 18836486. Epub 2008/10/07. eng)
66. M.D. Curley, V.A. Therrien, C.L. Cummings, P.A. Sergent, C.R. Koulouris, and A.M. Friel et al. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer (Dayton, Ohio) Stem Cells 27 12 Dec 2009 2875 2883 (PubMed PMID: 19816957. Epub 2009/10/10. eng)
67. A.P. Kusumbe, A.M. Mali, and S.A. Bapat CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature (Dayton, Ohio) Stem Cells 27 3 Mar 2009 498 508 (PubMed PMID: 19253934)
68. A.B. Alvero, R. Chen, H.H. Fu, M. Montagna, P.E. Schwartz, and T. Rutherford et al. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance Cell Cycle 8 1 Jan 1, 2009 158 166 (PubMed PMID: 19158483. Pubmed Central PMCID: 3041590)
69. S. Zhang, C. Balch, M.W. Chan, H.C. Lai, D. Matei, and J.M. Schilder et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors Cancer Res 68 11 Jun 1 2008 4311 4320 (PubMed PMID: 18519691. eng)
70. M.F. Shi, J. Jiao, W.G. Lu, F. Ye, D. Ma, and Q.G. Dong et al. Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line Cell Mol Life Sci 67 22 Nov 2010 3915 3925 (PubMed PMID: 20549538. Epub 2010/06/16. eng)
71. M.Q. Gao, Y.P. Choi, S. Kang, J.H. Youn, and N.H. Cho CD24 + cells from hierarchically organized ovarian cancer are enriched in cancer stem cells Oncogene 29 18 May 6, 2010 2672 2680 (PubMed PMID: 20190812. Epub 2010/03/02. eng)
72. I. Kryczek, S. Liu, M. Roh, L. Vatan, W. Szeliga, and S. Wei et al. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells Int J Cancer 130 1 Jan 1, 2012 29 39 (PubMed PMID: 21480217. Pubmed Central PMCID: 3164893)
73. L. Hu, C. McArthur, and R.B. Jaffe Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant Br J Cancer 102 8 Apr 13, 2010 1276 1283 (PubMed PMID: 20354527. Pubmed Central PMCID: 2856005. Epub 2010/04/01. eng)
74. J. Dou, C. Jiang, J. Wang, X. Zhang, F. Zhao, and W. Hu et al. Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line Cell Biol Int 35 3 Mar 1, 2011 227 234 (PubMed PMID: 21108606. Epub 2010/11/27. eng)